Oruka Therapeutics (ORKA) Capital Expenditures Growth (5y) (2015 - 2026)
Oruka Therapeutics (ORKA) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 947.75 Mn | 116.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.83% |
| Sep 30, 2025 | 75.18% |
| Jun 30, 2025 | 62.51% |
| Mar 31, 2025 | 34.08% |
| Dec 31, 2022 | -31.95% |
| Jun 30, 2021 | -63.19% |
| Mar 31, 2021 | -3.04% |
| Sep 30, 2020 | 24.57% |
| Jun 30, 2020 | -9.71% |
| Mar 31, 2020 | 8.45% |
| Dec 31, 2019 | -53.60% |
| Sep 30, 2018 | -22.88% |
| Mar 31, 2018 | -35.56% |
| Dec 31, 2016 | -78.59% |
| Mar 31, 2016 | 47.58% |
| Dec 31, 2015 | 151.69% |